cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Abcellera Biologics Inc
50 own
43 watching
Current Price
$4.08
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,295.5M
52-Week High
52-Week High
8.05000
52-Week Low
52-Week Low
3.58000
Average Volume
Average Volume
1.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,295.5M
icon52-Week High8.05000
icon52-Week Low3.58000
iconAverage Volume1.6M
iconDividend Yield--
iconP/E Ratio--
What does the Abcellera Biologics Inc do?
Our mission is to improve health with technologies that transform the way that antibody-based therapies are discovered. We aim to become the centralized operating system for next generation antibody discovery. Our full-stack, artificial intelligence-, or AI, powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. --- We were incorporated in 2012 under the Business Corporations Act (British Columbia), or the BCBCA. Our principal executive offices are located at 2215 Yukon Street Vancouver, British Columbia, V5Y 0A1, Canada and our telephone number is (604) 559-9005. We have six wholly owned subsidiaries, Lineage, a Delaware corporation, Trianni, a California corporation, AbCellera US Holdings Inc., a Delaware corporation, AbCellera Properties Inc., a BCBCA company, AbCellera Properties Columbia Inc., a BCBCA company, and Channel Biologics Pty Ltd., a proprietary company registered in New South Wales, Australia. Our website address is www.abcellera.com.
Read More
How much money does Abcellera Biologics Inc make?
News & Events about Abcellera Biologics Inc.
Business Wire
1 year ago
AbCellera (Nasdaq: ABCL) today presented new data on its T-cell engager (TCE) platform in two poster presentations at the American Society for Cancer Research (AACR) Annual Meeting 2023, which is being held at the Orange County Convention Center in Orlando, Florida, from April 14 to 19, 2023...
Business Wire
1 year ago
AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have entered into a strategic collaboration to identify optimal clinical candidates for up to three infectious disease targets selected by RQ Bio, including influenza and cytomegalovirus (CMV). The partnership aims to provide...
Ticker Report
1 year ago
Cowen assumed coverage on shares of AbCellera Biologics (NASDAQ:ABCL Get Rating) in a research report released on Tuesday, Marketbeat reports. The firm issued an outperform rating on the stock. Other research analysts have also issued research reports about the company. The Goldman Sachs ...
Ticker Report
1 year ago
AbCellera Biologics Inc. (NASDAQ:ABCL Get Rating) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 15,350,000 shares, a decline of 7.0% from the November 30th total of 16,510,000 shares. ...
Business Wire
1 year ago
AbCellera (Nasdaq: ABCL) and Rallybio Corporation (Nasdaq: RLYB) announced today that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases. This multi-year, multi-target collaboration will combine AbCelleras antibody...
Frequently Asked Questions
Frequently Asked Questions
What is Abcellera Biologics Inc share price today?
plus_minus_icon
Can Indians buy Abcellera Biologics Inc shares?
plus_minus_icon
How can I buy Abcellera Biologics Inc shares from India?
plus_minus_icon
Can Fractional shares of Abcellera Biologics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Abcellera Biologics Inc stocks?
plus_minus_icon
What is today’s traded volume of Abcellera Biologics Inc?
plus_minus_icon
What is today’s market capitalisation of Abcellera Biologics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Abcellera Biologics Inc?
plus_minus_icon
What percentage is Abcellera Biologics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Abcellera Biologics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.08
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00